These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5638549)

  • 1. The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids.
    Solomon HM; Schrogie JJ; Williams D
    Biochem Pharmacol; 1968 Jan; 17(1):143-51. PubMed ID: 5638549
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of phenylbutazone, tolbutamide, and clofibric acid on binding of racemic warfarin and its enantiomers to human serum albumin.
    Veronich K; White G; Kapoor A
    J Pharm Sci; 1979 Dec; 68(12):1515-8. PubMed ID: 529041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of various drugs on the binding of warfarin-14C to human albumin.
    Solomon HM; Schrogie JJ
    Biochem Pharmacol; 1967 Jul; 16(7):1219-26. PubMed ID: 6053595
    [No Abstract]   [Full Text] [Related]  

  • 4. Competition between diftalone and other drugs for the binding site(s) on human serum albumin.
    Assandri A; Perazzi A
    Med Biol; 1976 Jun; 54(3):187-92. PubMed ID: 940363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermodynamics of fatty acid anion displacement of warfarin and phenylbutazone from human albumin.
    Rippie EG
    Biochem Pharmacol; 1976 May; 25(10):1215-6. PubMed ID: 938544
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of free fatty acids on binding of drugs by bovine serum albumin, by human serum albumin and by rabbit serum.
    Rudman D; Bixler TJ; Del Rio AE
    J Pharmacol Exp Ther; 1971 Feb; 176(2):261-72. PubMed ID: 4105545
    [No Abstract]   [Full Text] [Related]  

  • 7. Binding of indomethacin to human serum albumin. Its non displacement by various agents, influence of free fatty acids and the unexpected effect of indomethacin on warfarin binding.
    Zini R; D'Athis P; Barre J; Tillement JP
    Biochem Pharmacol; 1979 Sep; 28(17):2661-5. PubMed ID: 518678
    [No Abstract]   [Full Text] [Related]  

  • 8. Displacement of tolbutamide, glibencalmide and chlorpropamide from serum albumin by anionic drugs.
    Brown KF; Crooks MJ
    Biochem Pharmacol; 1976 May; 25(10):1175-8. PubMed ID: 820348
    [No Abstract]   [Full Text] [Related]  

  • 9. The binding of sodium warfarin to plasma albumin and its displacement by phenylbutazone.
    O'Reilly RA
    Ann N Y Acad Sci; 1973 Nov; 226():293-308. PubMed ID: 4520398
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenytoin binding to human albumin.
    Lecomte M; Zini R; d'Athis P; Tillement JP
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):23-8. PubMed ID: 467465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of certain acidic drugs to human albumin: theoretical and practical estimation of fundamental parameters.
    Tillement JP; Zini R; d' Athis P; Vassent G
    Eur J Clin Pharmacol; 1974 Jul; 7(4):307-13. PubMed ID: 4850753
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of oleic acid, tolbutamide, and oxyphenbutazone on the binding of warfarin by human serum albumin.
    Wosilait WD; Ryan MP
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):577-84. PubMed ID: 504792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of drug binding sites on mammalian albumins.
    Panjehshahin MR; Yates MS; Bowmer CJ
    Biochem Pharmacol; 1992 Sep; 44(5):873-9. PubMed ID: 1382424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefazolin serum protein binding and its inhibition by bilirubin, fatty acids and other drugs.
    Decroix MO; Zini R; Chaumeil JC; Tillement JP
    Biochem Pharmacol; 1988 Jul; 37(14):2807-14. PubMed ID: 3395358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-binding properties of rat alpha-foetoprotein. Specificities of the phenylbutazone-binding and warfarin-binding sites.
    Hervé F; Rajkowski KM; Martin MT; Dessen P; Cittanova N
    Biochem J; 1986 Oct; 239(2):451-8. PubMed ID: 2434073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy.
    Vorum H; Honoré B
    J Pharm Pharmacol; 1996 Aug; 48(8):870-5. PubMed ID: 8887741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple factors affecting excretion of warfarin in rats.
    Pepper ES; Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):275-81. PubMed ID: 918347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    Fehske KJ; Schläfer U; Wollert U; Müller WE
    Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative interaction of sulfinpyrazone and phenylbutazone with racemic warfarin: alteration in vivo of free fraction of plasma warfarin.
    O'Reilly RA; Goulart DA
    J Pharmacol Exp Ther; 1981 Dec; 219(3):691-4. PubMed ID: 7299692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of fatty acids between serum albumin and red cell ghosts.
    Göransson G
    Acta Physiol Scand; 1968 Mar; 72(3):327-30. PubMed ID: 5659746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.